Markets

Johnston & Murphy announced a partnership with Peyton Manning as its brand ambassador for the Fall 2025 campaign. The campaign, developed with Wolfgang and Omaha Productions, uses humor to showcase the brand’s collection. Manning, a long-time fan, will feature in ads highlighting “Fashion Fumbles” and the “Wall of Game.” This collaboration aims to solidify the existing customer base and attract new consumers through athlete endorsement. The campaign coincides with Johnston & Murphy’s 175th anniversary and the launch of their XC+™ Extreme Comfort collection.

Quintauris and Everspin Technologies are collaborating to integrate MRAM solutions into the Quintauris RISC-V ecosystem, enhancing reliability and safety for automotive, industrial, and edge computing applications. This partnership aims to meet stringent data persistence, integrity, and security requirements. By combining Everspin’s MRAM with Quintauris’ architectures, this collaboration will address critical data maintenance needs under adverse conditions. The goal is to enable broader adoption of RISC-V in automotive and other safety-critical sectors with dependable platforms.

Energy Fuels Inc. priced a $600 million private placement of 0.75% Convertible Senior Notes due 2031, upsized from $550 million due to strong investor interest. Net proceeds will fund rare earth separation expansion at the White Mesa Mill, development of the Donald rare earth project in Australia, and general corporate purposes. The notes are convertible into cash, shares, or a combination thereof, with an initial conversion price of $20.34 per share. The company also entered into capped call transactions to mitigate potential dilution.

CoinShares, a leading European digital asset manager, has acquired Bastion Asset Management, a London-based, FCA-regulated alternative investment manager. This acquisition enhances CoinShares’ active management capabilities and aligns with its strategic goal of becoming a global leader in digital asset management. Bastion’s quantitative alpha investment approach and expertise will be integrated into CoinShares, facilitating the development of actively managed funds, particularly for the U.S. market, and strengthening CoinShares’ position as a comprehensive digital asset investment platform.

AAR CORP. (NYSE: AIR) announced the pricing of a public offering of 3,000,000 shares of common stock at $83.00 per share. Underwriters have an option to purchase up to 450,000 additional shares. Net proceeds, estimated at $239 million (potentially $274.9 million with the option), will primarily repay debt under its revolving credit facility and for general corporate purposes, including potential acquisitions. Goldman Sachs, Jefferies, and RBC Capital Markets are the joint lead book-running managers. The offering is expected to close around October 2, 2025.

Scryb (SCYRF) granted 3,870,000 stock options, exercisable at $0.12 per share for five years, to company stakeholders; 2,910,000 options were allocated to directors and officers. The grants fall under the Omnibus Long-Term Incentive Plan and include a four-month resale restriction. The company utilized exemptions under MI 61-101 regarding valuation and minority shareholder approval for insider participation, which may draw scrutiny. The options aim to incentivize personnel but also pose potential dilution risks.

GreenTree Hospitality Group reported its unaudited H1 2025 financial results, revealing a mixed performance. Total revenues decreased 14.2% year-over-year to RMB 585.1 million, while net income increased to RMB 198.8 million due to strategic investments. Adjusted EBITDA decreased by 22.2%. The company operated 4,509 hotels as of June 30, 2025, and opened 138 hotels during the period. Hotel RevPAR declined while restaurant ADS also decreased significantly.

Adicet Bio, Inc. announced an inducement award to a new employee joining in September 2025. The individual received a non-qualified stock option to purchase 9,800 shares at $0.81 per share, the closing price on the grant date. The options vest over four years with a one-year cliff, contingent upon continued employment. The award was granted under the 2022 Inducement Plan and approved by the independent compensation committee, adhering to Nasdaq Listing Rule 5635(c)(4). Adicet Bio focuses on allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.

Exiger, an AI-powered supply chain intelligence platform, was recognized as a Value Leader in Spend Matters™ Fall 2025 SolutionMap for the third consecutive time. Exiger received the highest functional scores in Third-Party Risk Management (TPRM) and Supply Chain Risk Management (SCRM). The SolutionMap assessment included 115 vendors and combines RFIs, technical assessments, and customer ratings. This recognition follows Exiger’s other recent achievements, including being named a Leader in Gartner® and Omdia reports. Exiger’s platform provides visibility, proactive risk surfacing, and automated compliance in supply chains.

bioAffinity Technologies announced the completion of a public offering, generating $4.8 million in gross proceeds. The offering included shares of common stock and pre-funded warrants. WallachBeth Capital, LLC served as the placement agent. bioAffinity focuses on non-invasive cancer diagnostics, including CyPath® Lung, a Laboratory Developed Test for early lung cancer detection. The company addresses the growing precision diagnostics market with a focus on improving patient outcomes through early diagnosis. The announcement contains forward-looking statements subject to risks detailed in SEC filings.